Friday, October 16, 2020 8:29:44 PM
Big deal if LQMT can use the patents. Read the PLA and see exactly what LQMT got by way of Eontec Patents, and search the USPTO for Eontec's patents. We got very little other than money.
So, at the time the PLA went into effect, the patents were listed in Appendix b. There are a total of six patents listed in Appendix b.
The PLA also said that patents "for any invention that is first created, conceived, or reduced to practice during the period beginning on the Effective Date and ending of the last day of the Joint Development Period." In other words, inventions after the PLA went into effect would also be included in the PLA. A search of the USPTO shows that there are 4 patents issued to Eontec.
Patent number 4 was filed in the US in 2015, which is before the PLA went into effect. Patent 4 was not listed in Appendix b, and it was not invented after the PLA went into effect. Consequently, it is dubious that patent 4 is licensed to LQMT. Furthermore, patent 4 is assigned to INSTITUTE OF METAL RESEARCH, CHINESE ACADEMY OF SCIENCES and Eontec. It is doubtful that the INSTITUTE OF METAL RESEARCH, CHINESE ACADEMY OF SCIENCES has agreed to license their IP to LQMT.
So, it appears that there might be all of three patents licensed to LQMT. Any of the patents listed in Appendix b that do not correspond to the four U.S. Patents can be used by anyone in the U.S.
Rally around LQMT. The serious investors shall be blessed and will hear the word of Li being directly communicated, almost miraculously, to them. Amen.
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM